Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Condition

Epidermolysis bullosa dystrophica

Diseases of the Skin and Subcutaneous Tissue

Epidermolysis bullosa dystrophica, also called dystrophic EB and abbreviated DEB, is an inherited disease that affects the skin and other organs. It is one of the forms of epidermolysis bullosa, the group of blistering skin disorders. Children born with the disease are colloquially called butterfly children, because their skin is as delicate and fragile as the wings of a butterfly. In the Medicine Atlas it is recorded as an inherited condition of the skin, kept as its own entry because the dystrophic form is a distinct disorder with its own course, separate from the broader epidermolysis bullosa entry.

Facts
Classification
Body System
Integumentary System 1
ICD-10 Chapter
XVII: Congenital Malformations, Deformations and Chromosomal Abnormalities 2
Communicable or Non-communicable
Non-Communicable 1
Causative Agent
Causative Agent (category)
Genetic / Hereditary 1
Connections

Treated By

Source Protein replacement therapy (Wikipedia)
Sources
1. Epidermolysis bullosa dystrophica (Wikipedia)
  • Lead paragraph
    affecting the skin and other organs
  • Lead paragraph [causative-agent-category]
    is an inherited disease affecting the skin and other organs
  • Lead: disease category
    Epidermolysis bullosa dystrophica or dystrophic EB (DEB) is an inherited disease affecting the skin and other organs. "Butterfly child" is the colloquial name for children born with the disease, as their skin is seen to be as delicate and fragile as the wings of a butterfly.
View the Source
2. World Health Organization: ICD-10 Version:2019 - Q81.2
World Health OrganizationICD-10 2019 category Q81.2, Chapter XVII
Quote, ICD-10 2019 category Q81.2, Chapter XVII
Q81.2 Epidermolysis bullosa dystrophica
View the Source
Protein replacement therapy (Wikipedia)
Treated By: Protein Replacement Therapy, Lead: treats Epidermolysis bullosa dystrophica
Quote, Treated By: Protein Replacement Therapy, Lead: treats Epidermolysis bullosa dystrophica
PRT is being tested in clinical trials with the diseases progeria and epidermolysis bullosa dystrophica as a potential treatment.
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.